John H Weis

Title: John H Weis: Innovator in Herpes Simplex Virus Research

Introduction

John H Weis is a notable inventor based in Brookline, MN (US). He has made significant contributions to the field of virology, particularly in the study of herpes simplex virus (HSV). His innovative work has implications for vaccine development and disease prevention.

Latest Patents

John H Weis holds a patent for the "Production of herpes simplex viral proteins." This patent describes methods and compositions for cloning and expressing the Herpes Simplex Virus (HSV type 1 or type 2) glycoprotein (gD) gene in single-cell host organisms. The techniques outlined in his patent enable the production of HSV-gene products, which can be formulated as immunogens in vaccines to protect against HSV-1 and HSV-2 infections. He has 1 patent to his name.

Career Highlights

Throughout his career, John has worked at the American Cyanamid Company, where he has focused on advancing research in viral proteins. His work has contributed to a better understanding of HSV and its potential treatments.

Collaborations

John H Weis has collaborated with notable colleagues, including Roger J Watson and Lynn W Enquist. These partnerships have fostered a collaborative environment that enhances research outcomes.

Conclusion

John H Weis is a distinguished inventor whose work in herpes simplex virus research has the potential to impact vaccine development significantly. His contributions to the field are invaluable and continue to pave the way for advancements in virology.